UNSPSC 51111844: Fadrozole

This classification denotes a non-steroidal aromatase inhibitor with the molecular formula C14H13N3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier H3988M64PU, chemically known as benzonitrile, 4-(5,6,7,8-tetrahydroimidazo(1,5-a)pyridin-5-yl)- but generally known as fadrozole, which bears US NIH Compound Identifier 59693. European Medicines Agency schedules Fadrozole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07497MIG.

UNSPSC 51111844 Fadrozole is a Commodity-tier code for a specific aromatase inhibitor pharmaceutical used in breast cancer treatment. State and local governments procure this drug primarily through public health departments, Medicaid agencies, and state correctional health systems for use in institutional and community health settings. The code represents a narrow therapeutic category within oncology pharmaceuticals, and procurement typically occurs through established drug formularies, group purchasing organizations (GPOs), and state pharmaceutical contracts rather than through competitive solicitations specific to individual drugs.

The source provides no recent state or local contract opportunities tagged to this code. Without documented solicitation activity, the code does not present a current pursuit signal for business development purposes.